CV Lattes
ResearcherID
ORCID
Secretaria de Desenvolvimento Econômico (São Paulo - Estado). Instituto de Pesquisas Energéticas e Nucleares (IPEN) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Bachelor's in Pharmacy from Universidade de Sorocaba (2009) and doctorate in Nuclear Technologies - materials at Instituto de Pesquisas Energéticas e Nucleares (2014) with scholarship from Fundação de Amparo a Pesquisa no Estado de São Paulo (FAPESP) and financial support from International Atomic Energy Agency (AIEA). Author of patents and manuscripts at national and international level. Scientific reviewer of journals of international and national relevance. Editorial board member of International Scientific Journals and Associate Editor at Radiation Physics and Chemistry journal. Currently a pos-doc at IPEN with a scholarship from FAPESP. Research expertise involves the development of micro/nanostructured advanced and controlled drug release systems; Pharmaceutical protein immobilization/stabilization; Radiation technology applied to R&D of pharmaceuticals, responsive devices, biomaterials and protein based nanocarriers and tissue engineering. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Nanotechnology has broadened the options for delivery of agents of biotechnological and clinical relevance. Regarding antitumor/cancer drugs lots of attention has been driven nowadays towards taxanes formulation using protein particles at nano/sub-micron level. Paclitaxel and albumin complexes are theme of constant research and received final approval for commercialization this decade. In…
Papain is a proteolytic enzyme that holds debridement properties, commonly used for wound treatment. A natural unfolding mechanism, as well as incompatibilities with several substances, decreases its bioactivity and shelf life. Recently the FDA has taken an action against papain containing topical products due to severe adverse events reported in patients submitted to papain treatments, r…
| 1 / 1 | Completed research grants |
| 2 / 2 | Completed scholarships in Brazil |
| 3 / 3 | All research grants and scholarships |
| Associated processes | |